Wellnex Life Ltd (ASX: WNX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Wellnex Life Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$5.53 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
69.96 million
Earnings per share
-0.304
Dividend per share
N/A
Year To Date Return
-18.09%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Wellnex Life Ltd (ASX: WNX)
Latest News
Share Market News
Here's why the Wellnex Life (ASX:WNX) share price jumped 37% today
Share Fallers
Why the Wellnex Life (ASX:WNX) share price is crashing 75% lower on Thursday
Capital Raising
ASX infant formula group Wattle Health to raise $39.7 million in new shares
⏸️ Growth Investing
Can ASX infant formula shares soar in 2020?
Share Market News
Infant formula company Wattle Health to remain suspended after failed rights issue
Share Market News
Wattle Health announces deal with Chemist Warehouse
Share Market News
Wattle Health announces new China-based joint venture
Share Fallers
Why Clinuvel, Newcrest, Starpharma, & Wattle Health shares dropped lower
Share Fallers
Why Beach, Pro Medicus, South32, & Wattle Health tumbled lower today
Share Market News
Why ARQ, Fortescue, iSignthis, & Wattle Health shares are sinking lower
Share Gainers
The Wattle Health share price is up 95% in a week
Share Gainers
Why Clover, IOOF, Premier Investments, & Wattle Health surged higher today
WNX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Wellnex Life Ltd
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.
WNX Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 18 Mar 2026 | $0.08 | $0.00 | 0.00% | 60,607 | $0.08 | $0.08 | $0.08 |
| 16 Mar 2026 | $0.08 | $-0.01 | -12.20% | 51,623 | $0.08 | $0.08 | $0.08 |
| 13 Mar 2026 | $0.08 | $0.00 | 0.00% | 78,936 | $0.09 | $0.09 | $0.08 |
| 12 Mar 2026 | $0.09 | $0.00 | 0.00% | 115,294 | $0.09 | $0.09 | $0.09 |
| 11 Mar 2026 | $0.09 | $-0.01 | -10.42% | 46,150 | $0.09 | $0.09 | $0.09 |
| 10 Mar 2026 | $0.10 | $0.00 | 0.00% | 18,336 | $0.10 | $0.10 | $0.10 |
| 09 Mar 2026 | $0.09 | $0.00 | 0.00% | 101,110 | $0.09 | $0.09 | $0.09 |
| 06 Mar 2026 | $0.10 | $0.00 | 0.00% | 1,939 | $0.09 | $0.10 | $0.09 |
| 05 Mar 2026 | $0.10 | $0.00 | 0.00% | 89,076 | $0.10 | $0.11 | $0.10 |
| 04 Mar 2026 | $0.10 | $0.00 | 0.00% | 11,105 | $0.10 | $0.10 | $0.10 |
| 03 Mar 2026 | $0.10 | $0.00 | 0.00% | 10,295 | $0.10 | $0.10 | $0.10 |
| 02 Mar 2026 | $0.10 | $-0.01 | -9.52% | 50,786 | $0.11 | $0.11 | $0.10 |
| 27 Feb 2026 | $0.11 | $0.00 | 0.00% | 478,062 | $0.12 | $0.12 | $0.10 |
| 26 Feb 2026 | $0.11 | $-0.01 | -8.70% | 186,041 | $0.11 | $0.11 | $0.10 |
| 25 Feb 2026 | $0.12 | $0.01 | 9.09% | 25,000 | $0.12 | $0.12 | $0.12 |
| 24 Feb 2026 | $0.11 | $0.00 | 0.00% | 30,000 | $0.11 | $0.11 | $0.11 |
| 23 Feb 2026 | $0.11 | $0.00 | 0.00% | 28,000 | $0.11 | $0.11 | $0.11 |
| 20 Feb 2026 | $0.11 | $0.00 | 0.00% | 3,368 | $0.11 | $0.11 | $0.11 |
| 19 Feb 2026 | $0.11 | $0.00 | 0.00% | 54,145 | $0.11 | $0.12 | $0.11 |
| 18 Feb 2026 | $0.11 | $-0.01 | -8.33% | 16,542 | $0.12 | $0.12 | $0.11 |
| 17 Feb 2026 | $0.12 | $0.01 | 9.09% | 25,101 | $0.12 | $0.12 | $0.12 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 22 Dec 2025 | Jeffrey Yeh | Transfer | 1,285,409 | $128,540 |
As advised by the company. $ 732,795.85
|
| 22 Dec 2025 | Jeffrey Yeh | Transfer | 890,609 | $89,060 |
Off-market transfer. $ 732,795.85
|
| 21 Jul 2025 | Eric Jiang | Expiry | 1,191 | $291 |
Options expired. As per annoucnement on 25-07-2025
|
| 21 Jul 2025 | George Karafotias | Expiry | 15,239 | $3,733 |
Options expired. As per announcement on 25-06-2025
|
| 21 Jul 2025 | Jeffrey Yeh | Expiry | 1,554,844 | $380,936 |
Options expired.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Eric Jiang | Executive DirectorInterim Chairman | Mar 2026 |
Mr Jiang is a public company director and corporate adviser with more than 25 years of experience in capital markets, corporate strategy and international business development, and has served on the Wellnex board since 2017. He has served on the boards of several ASX-listed companies and brings expertise in governance, capital raising and strategic growth initiatives.
|
| Mr Jeffrey Yeh | Non-Executive Director | Jan 2024 |
Mr Jeffrey Yeh is an all-rounded entrepreneur, with over 21 years' experience in all aspects of pharmaceutical sales, marketing, production, quality assurance, operations, logistics, finance and management.
|
| Mr Ash Vesali | Non-Executive Director | Sep 2025 |
Mr Vesali has 20 years of global experience in manufacturing and top-tier consulting, supporting ASX executives and boards on strategy, governance, performance improvement and business resiliency. He has delivered operational excellence through governance reform and cost restructuring and led turnarounds with disciplined capital allocation.
|
| Mr Zheng (Kobe) Li | Company Secretary | Jan 2019 |
-
|
| Zheng (Kobe) Li | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Computershare Clearing Pty ltd (CCNL DI A/C) | 12,620,320 | 18.62% |
| Citicorp Nominees Pty Limited | 4,147,717 | 6.12% |
| Homart Group Pty Ltd | 3,427,010 | 5.06% |
| JYSF Management Pty Ltd (JYSF A/C) | 2,629,181 | 3.88% |
| J P Morgan Nominees Australia Pty Limited | 1,480,610 | 2.18% |
| Lotus Capital Group Pty Ltd | 1,398,567 | 2.06% |
| Kobella Holdings Pty Ltd (The Kobella Holding Unit A/C) | 1,371,429 | 2.02% |
| Major Halfpenny Pty Ltd (Palfreymanfamily S/F A/C) | 1,053,846 | 1.55% |
| JLO Enterprises Pty ltd (The Kobella Holding Unit A/C) | 1,015,000 | 1.50% |
| Mr James Moussa and Mrs Tracey Ann Moussa (PJET Super Fund) | 903,324 | 1.33% |
| 365 Health Australia Pty Ltd | 883,996 | 1.30% |
| Mr Reid Jon Zulpo and Mrs Melissa Catherine Zilpo (RJ & MC Zulpo Family A/C) | 866,317 | 1.28% |
| Kirby Superannuation Pty Ltd (Kirby Super Fund A/C) | 803,096 | 1.19% |
| Netwealth Investments Limited (Wrap Services A/C) | 787,888 | 1.16% |
| HSBC Custody Nominees (Australia) Limited | 754,967 | 1.11% |
| Appwam Pty Ltd | 750,666 | 1.11% |
| Reach Investment Group Nominees Pty Ltd (R Markets Unit A/C) | 720,787 | 1.06% |
| ZJL Pty Ltd (The Bozinovski Family A/C) | 667,473 | 0.98% |
| GGP Investments Pty Ltd (GGP Superannuation Fund A/C) | 654,656 | 0.97% |
| Mr Jonathan Charles Minor and Ms Cherle-Lynn Mcconnell (Mcconnell Minor Family A/C) | 600,000 | 0.89% |